Skip to main content

Table 3 General health score and general health score component frequency within the validation/test population

From: Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs

 

General disease status group

Low tertile

Medium tertile

High tertile

Patients, n

4400

3426

3559

General health score

 Mean (SD)

0.00 (0.00)

5.72 (0.31)

16.07 (7.22)

 Median (IQR)

0.00 (0.00–0.00)

5.78 (5.42–5.89)

12.14 (11.13–17.46)

 Minimum

0

5.24

8.94

 Maximum

0

6.25

64.82

General health score components, n (%)

 Myocardial infarction

0

0

47 (1.3)

 Metastatic solid tumor

0

0

45 (1.3)

 Any primary malignancy

0

0

363 (10.2)

 Drug/device complication

0

0

658 (18.5)

 Diabetes with chronic complications

0

0

159 (4.5)

 Hematologic

0

329 (9.6)

1038 (29.2)

 Gastrointestinal disease

0

1033 (30.2)

2301 (64.7)

 Psychiatric

0

1190 (34.7)

2090 (58.7)

 Rheumatologic

0

31 (0.9)

125 (3.5)

 Genitourinary

0

843 (24.6)

1876 (52.7)

  1. IQR interquartile range, MS multiple sclerosis, SD standard deviation